All Articles
FundingPortfolio
Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and…
PerspectivePortfolio
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference
For those in healthcare, JPM provides the unofficial kickoff to every new year with a chance to recap the year before and inform our…
Perspective
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world…
PortfolioPerspective
Video: Reengineering Drug Discovery With Recursion
Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.
PortfolioFundingPerspective
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna
Cancer remains one of the leading causes of death in the U.S. and worldwide.